PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Excellus BlueCross BlueShieldCommercial · Administrative · Eyes (Ophthalmology) · OphthalmologyLow impact

Aqueous Drainage Devices (Stents and Shunts) for Glaucoma 9.01.18

Effective date
Jan 22, 2026
Identified
Jun 20, 2026

Summary

Excellus BlueCross BlueShield policy 9.01.18 considers FDA-approved aqueous drainage devices medically appropriate for glaucoma when medical therapy has failed to adequately control intraocular pressure or when oral or topical medications are not tolerated. It considers implanting one or two FDA-approved micro-stents, such as iStent or iStent Inject, with cataract surgery medically appropriate for mild-to-moderate open-angle glaucoma treated with ocular hypotensive medication. Suprachoroidal or supraciliary placement, and all other uses, are considered investigational. The January 22, 2026 annual review changed the policy title and left the policy intent unchanged.

Get alerts when payers change rules like this one

We check Excellus BlueCross BlueShield and other payers every day and email you when a change matches your specialty and state.

Get Excellus BlueCross BlueShield alertsPolicy Monitoring is free. No card required.

What to do

Action · 3 steps
01Already effective January 22, 2026: Billing team should confirm that each aqueous drainage device claim meets one of the listed indications, either failed medical therapy with intraocular pressure not adequately controlled or medications not tolerated, such as oral medications causing significant gastrointestinal effects or topical medications causing contact sensitivity or systemic effects.
02For micro-stents placed with cataract surgery, confirm the diagnosis is mild-to-moderate open-angle glaucoma and that the patient is currently treated with ocular hypotensive medication.
03Use of aqueous drainage devices for glaucoma when intraocular pressure is adequately controlled by medications is considered investigational under this policy.

Codes mentioned

66179661806618366184661856698966991C1783L8612

Original notice

Aqueous Drainage Devices (Stents and Shunts) for Glaucoma 9.01.18
excellusbcbs.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account